12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

GlaxoSmithKline, French National Institute of Health and Medical Research (Inserm), Imagine Institute deal

GlaxoSmithKline partnered with the Imagine Institute to discover and develop compounds to treat Netherton syndrome, a rare inherited skin disorder characterized by chronic skin inflammation, itch, severe dehydration and stunted growth. The partners...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >